Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
09/22/1988 | WO1988007057A1 Purified platelet-derived growth factor and methods for purification thereof |
09/22/1988 | WO1988007056A1 METHOD AND KIT FOR CONTRACEPTION WITH GnRH-ANTAGONIST AND PROGESTIN |
09/22/1988 | WO1988007055A1 Diagnostic agents for systemic vasculitis |
09/22/1988 | WO1988007053A1 Renin inhibitors containing a cyclopropyl amino acid and/or a cycloalkyl transition-state analogue |
09/22/1988 | WO1988006891A1 Method for therapy of leukemias and certain other malignancies |
09/22/1988 | WO1988006890A1 Synthetic inhibitors of mammalian collagenase |
09/22/1988 | WO1988006881A1 Method of producing high aqueous volume multilamellar vesicles |
09/22/1988 | WO1988006843A1 BOVINE INTERLEUKIN-1beta |
09/22/1988 | WO1988006837A2 STRUCTURE OF IgG PLUS ANTIGEN AND COMPLEMENT, ITS MECHANISMS AND ITS IMPORTANT CONSEQUENCES |
09/22/1988 | DE3707710A1 Biologically active eicosapeptides, process for their preparation and their use |
09/21/1988 | EP0283458A2 Somatropin prolonged release |
09/21/1988 | EP0283442A1 Process for the manufacture of gastro-resistant and enterosoluble small spheres of digestive enzyme and pharmaceutical preparation so obtained |
09/21/1988 | EP0283365A1 Peptide derivatives of CCK8, their manufacture and pharmaceutical compositions thereof |
09/21/1988 | EP0283327A2 Peptides with the immunological properties of HIV-2 |
09/21/1988 | EP0283244A1 Superoxide dismutase polymers |
09/21/1988 | EP0282899A2 Human manganese superoxide dismutase (hMn-SoD) |
09/21/1988 | EP0282891A2 New thymopentin retro-inverso analogs and fragments thereof, a process of preparation of the new compounds and the intermediates obtained therein |
09/21/1988 | EP0282564A1 Inhibition of protein kinase c by long-chain bases |
09/21/1988 | EP0282550A1 Insulin precursors |
09/21/1988 | EP0282501A1 Regulating animal reproduction |
09/21/1988 | CN87107991A Human apolipoprotein ai and variant form of same expressed in escherichia coli |
09/20/1988 | US4772721 N.sup.τ -substituted histidine derivatives |
09/20/1988 | US4772686 Anticoagulants |
09/20/1988 | US4772684 Hypotensive or hypertensive |
09/20/1988 | US4772595 Synthetic virginiamycin M1 analogs |
09/20/1988 | US4772588 Treatment of parasitic diseases with calf thymus extract |
09/20/1988 | US4772587 Antiammesia agent, prolyl endopeptidase inhibitor |
09/20/1988 | US4772586 Novel derivatives of arginine vasopressin antagonists |
09/20/1988 | US4772585 Protein thrombolytic agent with absorption enhancing agent |
09/20/1988 | US4772584 Inhibitor of C5a-mediated chemotaxis |
09/20/1988 | US4772552 Monoclonal antibody which recognizes a 200-220 KD antigen on natural killer cells |
09/20/1988 | US4772464 Monoclonal antibodies which inhibit motility of bacteria |
09/20/1988 | CA1242158A1 Human monoclonal antibodies from lymphocytes of patients with malignant melanoma |
09/15/1988 | DE3706731A1 Cardiodilatin fragment and process for obtaining cardiodilatin fragments |
09/14/1988 | EP0282374A1 Peptide derivatives with a polycyclic nitrogen structure, process for their preparation and pharmaceutical compositions containing them |
09/14/1988 | EP0282363A2 Method for preparation of a concentrate of alpha-1-antitrypsin from a human plasma fraction, and its use as a pharmaceutical |
09/14/1988 | EP0282343A2 Method to stimulate the immune response to specific antigens |
09/14/1988 | EP0282319A2 Porcine growth hormone analogs |
09/14/1988 | EP0282318A2 Bovine growth hormone analogs |
09/14/1988 | EP0282317A2 Purified platelet-derived growth factor and methods for purification thereof |
09/14/1988 | EP0282219A1 Aminoethylphosphinic acid derivatives |
09/14/1988 | EP0282185A1 Human interleukin-3 and muteins thereof |
09/14/1988 | EP0282042A2 Fusion proteins and their purification |
09/14/1988 | EP0282020A2 Pharmaceutical preparations containing non-steroidal anti-inflammatory agents |
09/14/1988 | EP0281978A2 Inactivation of human immunodeficiency virus (HIV) in proteinic solutions by means of phenol |
09/14/1988 | EP0281822A2 Basic fibroblast growth factor mutein, DNA and its use |
09/14/1988 | EP0281809A2 Sustained release compositions for parenteral administration and their use |
09/14/1988 | EP0281734A2 Polypeptide having an antibacterial activity, and its use |
09/14/1988 | EP0281673A1 Plasmid for production of membrane protein, bacterium containing same, monoclonal antibody therefore, and method for the identification of haemophilus influenzae |
09/14/1988 | EP0281579A1 Cofactor of prourokinase |
09/14/1988 | EP0111549B1 Inactivation of a lipid virus |
09/14/1988 | CN88101000A Substituted alkylamides of teicoplania compounds |
09/13/1988 | US4771124 Treatment of osteoporosis, hypercalcemia, hyperparathyroidism, tumors, immune diseases |
09/13/1988 | US4771122 Novel cyclosporins |
09/13/1988 | US4771121 Microbiocides |
09/13/1988 | US4771038 Hydroxamic acids |
09/13/1988 | US4771037 N-carboxyalkyl compounds |
09/13/1988 | US4771036 Topical administration of thioredoxin |
09/13/1988 | CA1241950A1 Gnrh antagonists |
09/13/1988 | CA1241949A1 Acid-cleavable compound |
09/08/1988 | DE3804590A1 Diagnostic probes for detecting elastase-modified antithrombin and method of treatment |
09/07/1988 | WO1988006628A1 Platelet related growth regulator |
09/07/1988 | WO1988006625A2 Arginine-depleted human tumor necrosis factor |
09/07/1988 | WO1988006601A1 Gene repressors |
09/07/1988 | WO1988006600A1 Substituted alkylamides of teicoplanin compounds |
09/07/1988 | WO1988006599A1 Novel insulin derivatives |
09/07/1988 | WO1988006598A1 Vasoactive intestinal peptide analogs |
09/07/1988 | WO1988006597A1 New synthetic bioactive compounds and method of producing bioactive effect |
09/07/1988 | WO1988006596A1 New cardiodilatin fragment, process for preparing same and use thereof |
09/07/1988 | WO1988006595A1 General cancer-associated scm-recognition factor, preparation and method of use |
09/07/1988 | WO1988006592A1 Cloning of lfa-1 |
09/07/1988 | WO1988006456A1 Stable interferon complexes |
09/07/1988 | WO1988006455A1 Antibodies against streptococcus |
09/07/1988 | WO1988006453A1 Liver lactogenic factor |
09/07/1988 | WO1988006452A1 Compositions for enhancing adcc therapy |
09/07/1988 | WO1988006451A1 Immunosuppression in immunotoxin based human therapy |
09/07/1988 | WO1988006438A1 Pharmacological agent-lipid solution preparation |
09/07/1988 | WO1988006437A1 Process for preparing liposome |
09/07/1988 | EP0281435A1 Therapeutical product based on organic silicon compounds |
09/07/1988 | EP0281412A2 Novel organic platinum complex pharmaceutical compositions containing same and a process for the preparation thereof |
09/07/1988 | EP0281380A2 Synergistic interplay of interleukin-2 and dsRNAs |
09/07/1988 | EP0281363A2 Platelet related growth regulator |
09/07/1988 | EP0281316A2 Renin inhibitors |
09/07/1988 | EP0281299A1 Stable interferon complexes |
09/07/1988 | EP0281090A2 Tendamistate derivatives |
09/07/1988 | EP0281089A2 Process for the preparation of factor VIII:C deficient plasma, and deficient plasma obtained therwith |
09/07/1988 | EP0281070A2 Pharmaceutical composition for the treatment of cancer |
09/07/1988 | EP0280999A2 Stabilized pharmaceutical compositions containing angiotensin-converting enzyme inhibitors |
09/07/1988 | EP0280859A2 Polypeptide having an antiviral activity, and its use |
09/07/1988 | EP0261239A4 Fsh-releasing peptide. |
09/07/1988 | CN88100995A Glycine compounds and process for preparing them |
09/07/1988 | CN88100913A Polypeptide, dna and its use |
09/06/1988 | US4769383 Dioxonaphthotriazoles having antiallergic activity |
09/06/1988 | US4769362 Increased vascular perfusion following administration of lipids |
09/06/1988 | US4769361 Method for purifying and isolating two ionic forms of somatomedin C |
09/06/1988 | US4769336 Treatment of factor VIII inhibitors |
09/06/1988 | US4769328 Platelet derived growth factor |
09/06/1988 | US4769240 Pili of neisseria and vaccine compositions containing same |
09/06/1988 | US4769233 Structure and properties of modified interferons |
09/06/1988 | CA1241646A1 Atrial natriuretic factor |